6 completed, 2 recruiting, 1 active not recruiting, 1 enrolling by invitation. 5 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 2, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow HIV Infection Primary: new trials by email Literature Review of HIV Infection Primary trials Research Report on HIV Infection Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intervention to Enhance PrEP Persistence RAMP-It-Up Initiation, Adherence, and Retention Intervention - HIV Prevention, HIV Infection Primary | Not applicable | Recruiting | Brown University | 300 | 2024-10-01 | 2026-10-16 |
| Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes an adaptation of the iENGAGE - HIV Infection Primary | Not applicable | Active not recruiting | Florida International University | 66 | 2024-06-03 | 2026-07-10 |
| Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment Dasatinib 70 mg, Placebo - HIV Infection Primary | Phase 2 | Completed | Fundació Institut Germans Trias i Pujol | 60 | 2023-10-16 | 2025-09-22 |
| Integrated Navigation Services for Treatment Adherence, Counseling, and Research INSTACARE - HIV Infection Primary | Not applicable | Recruiting | University of Miami | 10 | 2023-07-26 | 2026-06-29 |
| The Visceral Adiposity Measurement and Observation Study Diagnostic Test, HIV Anti-retroviral Background Therapy - HIV, HIV-Infections | Completed | Theratechnologies | 196 | 2022-04-18 | 2023-11-18 | |
| Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis Tenofovir Disoproxil Fumarate 300 MG Oral Tablet - HIV Infection Primary, Hepatitis, Viral, Human | Enrolling by invitation | Hospitales Universitarios Virgen del Rocío | 500 | 2020-01-01 | 2023-09-22 | |
| Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study HIV testing - HIV Infections, Risk Reduction | Not applicable | Completed | Evandro Chagas National Institute of Infectious Disease | 4000 | 2019-10-01 | 2023-01-06 |
| Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities HIV Infection Primary | Completed | Northwell Health | 170 | 2017-12-12 | 2023-09-29 | |
| Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection Dolutegravir - HIV Infection Primary | Phase 3 | Completed | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 20 | 2017-01-01 | 2019-10-30 |
| Alcohol and ART Adherence in India Behavioral intervention - Alcohol Consumption, HIV Infection Primary | Not applicable | Completed | UConn Health | 940 | 2015-05-10 | 2018-12-11 |
HIV Infections (2) · Acquired Immunodeficiency Syndrome (1) · Alcohol Drinking (1) · Chemsex (1) · Fatty Liver (1) · HIV Seropositivity (1) · HIV-Associated Lipodystrophy Syndrome (1) · Health Risk Behaviors (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Homosexuality (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Non-alcoholic Fatty Liver Disease (1) · Risk Reduction Behavior (1)
Behavior (3) · Communicable Diseases (3) · Genital Diseases (3) · Infections (3) · Urogenital Diseases (3) · Virus Diseases (3) · Blood-Borne Infections (2) · Digestive System Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Lentivirus Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · RNA Virus Infections (2) · Retroviridae Infections (2)
Behavior Therapy (1) · Dasatinib (1) · Diagnostic Tests, Routine (1) · Emtricitabine (1) · HIV Testing (1) · Hematologic Tests (1) · Tablets (1) · Tenofovir (1) · Tomography, X-Ray Computed (1) · Urination (1) · dolutegravir (1)
Brown University (1) · Evandro Chagas National Institute of Infectious Disease (1) · Florida International University (1) · Fundació Institut Germans Trias i Pujol (1) · Hospitales Universitarios Virgen del Rocío (1) · Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba (1) · Northwell Health (1) · Theratechnologies (1) · UConn Health (1) · University of Miami (1)
United States (6) · Spain (2) · Brazil (1)
Avina Sarna, MD (1) · Frances R Wallach, MD (1) · Jean J Schensul, PhD (1) · Jeffery Carr, DR (1) · John Koethe, MD (1) · Jordan Lake, MD (1) · Karin Neukam, PharmD, PhD (1) · Marta Herrero Romero, MD, PhD (1) · Niranjan Saggurti, PhD (1) · Sonjia Kenya, EdD (1) · Stephen L Schensul, PhD (1)
PMID 28873452, PMID 28930059, PMID 28993911, PMID 30349875, PMID 34014429, PMID 37107849, PMID 38076411, PMID 39073518, PMID 40193336, PMID 40844326, PMID 41511671
R01MD018187 (1), R01MH131475 (1)